Age-stratified effects of intravenous ferric derisomaltose in heart failure with iron deficiency: insights from the IRONMAN trial
(2025)
Journal Article
Sze, S., Squire, I., Kalra, P. R., Cleland, J. G., Petrie, M. C., Kalra, P. A., …Ford, I. (2025). Age-stratified effects of intravenous ferric derisomaltose in heart failure with iron deficiency: insights from the IRONMAN trial. Heart, heartjnl-2024-324908. https://doi.org/10.1136/heartjnl-2024-324908
Background: Intravenous iron therapy with ferric derisomaltose (FDI) has been shown to improve outcomes in patients with heart failure with reduced ejection fraction (HFrEF) and iron deficiency. However, its effects across different age groups remain... Read More about Age-stratified effects of intravenous ferric derisomaltose in heart failure with iron deficiency: insights from the IRONMAN trial.